Siemens Healthineers

Results confirmed that Caas vFFR is a safe and effective alternative to conventional pressure wire-based physiology for guiding treatment decisions in patients with intermediate coronary artery stenosis.

The company showcased three new angiography platforms—Artis genio, Artis icono.explore, and Artis icono.vision—which harness artificial intelligence to enhance the precision of liver cancer embolization treatments.

Visitors will explore the latest advancements to improve patient outcomes and operational efficiency through integrated clinical pathways that demonstrate a connected approach from early detection through treatment.

The new Irish facility aims to accelerate innovation and bring next-generation diagnostic capabilities to hospitals and laboratories worldwide.

The partnership will bring more than 230 advanced medical systems to 19 public hospitals throughout the country.

The ACCESS-AD project launches in January 2026 with an ambitious goal to establish a collaborative, patient-centered approach to Alzheimer’s care throughout Europe.

The software works with both dual-source and photon-counting CT scanners to provide advanced diagnostic capabilities.

Optiq AI is integrated across three new imaging platforms: Artis genio, Artis icono.explore, and Artis icono.vision/Artis pheno.vision.